Insider Buying: Steven Collis Acquires Shares of Elevance Health Inc (ELV)

robot
Abstract generation in progress

Steven Collis, a Director at Elevance Health Inc (ELV), recently purchased 3,000 shares, increasing his total holdings to 3,639 shares. This transaction occurred on March 5, 2026, with the stock trading at $289.84. Elevance Health is currently considered significantly undervalued based on its GF Value, with a price-to-GF-Value ratio of 0.5.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin